Literature DB >> 26201323

Immunity and inflammatory signaling in alcoholic liver disease.

Pranoti Mandrekar1, Aditya Ambade2.   

Abstract

The pathogenesis of alcoholic liver disease (ALD) is multifactorial and characterized by steatosis, steatohepatitis and cirrhosis. Several signaling pathways in different liver cell types that contribute to the development and progression of alcoholic liver injury have been identified. Among these, immune cells and signaling pathways are the most prominent and central to ALD. Both innate and adaptive immune responses contribute to ALD. The key features of inflammatory pathways in ALD including liver innate and adaptive immune cell types, signaling receptors/pathways, and pro- and antiinflammatory/protective responses are summarized here.

Entities:  

Keywords:  ALD; ASH; Cytokines; Hepatic inflammation; Immunity; PRRs

Year:  2014        PMID: 26201323      PMCID: PMC4587491          DOI: 10.1007/s12072-014-9518-8

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  49 in total

1.  Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways.

Authors:  Masahide Miyamoto; Olof Prause; Margareta Sjöstrand; Martti Laan; Jan Lötvall; Anders Lindén
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

2.  Activation of toll-like receptor 3 attenuates alcoholic liver injury by stimulating Kupffer cells and stellate cells to produce interleukin-10 in mice.

Authors:  Jin-Seok Byun; Yang-Gun Suh; Hyon-Seung Yi; Young-Sun Lee; Won-Il Jeong
Journal:  J Hepatol       Date:  2012-09-27       Impact factor: 25.083

3.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

4.  Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice.

Authors:  Sayaka Inokuchi; Hidekazu Tsukamoto; EekJoong Park; Zhang-Xu Liu; David A Brenner; Ekihiro Seki
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

5.  Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production.

Authors:  Liang Shi; Raj Kishore; Megan R McMullen; Laura E Nagy
Journal:  J Biol Chem       Date:  2002-02-20       Impact factor: 5.157

6.  The interleukin-17 pathway is involved in human alcoholic liver disease.

Authors:  Arnaud Lemmers; Christophe Moreno; Thierry Gustot; Raphaël Maréchal; Delphine Degré; Pieter Demetter; Patricia de Nadai; Albert Geerts; Eric Quertinmont; Vincent Vercruysse; Olivier Le Moine; Jacques Devière
Journal:  Hepatology       Date:  2009-02       Impact factor: 17.425

7.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

Review 8.  Signalling pathways in alcohol-induced liver inflammation.

Authors:  Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Hepatol       Date:  2009-03-28       Impact factor: 25.083

9.  Characterization of human liver dendritic cells in liver grafts and perfusates.

Authors:  Brenda M Bosma; Herold J Metselaar; Shanta Mancham; Partrick P C Boor; Johannes G Kusters; Geert Kazemier; Hugo W Tilanus; Ernst J Kuipers; Jaap Kwekkeboom
Journal:  Liver Transpl       Date:  2006-03       Impact factor: 5.799

10.  Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury.

Authors:  Andrew M Miller; Hua Wang; Ogyi Park; Norio Horiguchi; Fouad Lafdil; Partha Mukhopadhyay; Akira Moh; Xin Yuan Fu; George Kunos; Pal Pacher; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2010-01-26       Impact factor: 3.455

View more
  4 in total

Review 1.  Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Yigang Feng; Xuanbin Wang; Yibin Feng
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

2.  Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells.

Authors:  Myung-Ho Kim; Hee-Hoon Kim; Jong-Min Jeong; Young-Ri Shim; Jun-Hee Lee; Ye Eun Kim; Tom Ryu; Keungmo Yang; Kyu-Rae Kim; Byeong-Min Jeon; Sun Chang Kim; Jae-Kwang Jung; Jae-Kap Choi; Young-Sun Lee; Jin-Seok Byun; Won-Il Jeong
Journal:  J Ginseng Res       Date:  2020-04-10       Impact factor: 6.060

3.  Modulation of gut microbiota mediates berberine-induced expansion of immuno-suppressive cells to against alcoholic liver disease.

Authors:  Sha Li; Ning Wang; Hor-Yue Tan; Fan Chueng; Zhang-Jin Zhang; Man-Fung Yuen; Yibin Feng
Journal:  Clin Transl Med       Date:  2020-08-13

Review 4.  A Perspective Of Intestinal Immune-Microbiome Interactions In Alcohol-Associated Liver Disease.

Authors:  Ryan Bruellman; Cristina Llorente
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.